Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1274256 | 1.00 | ALDH1A1 (0.32) | ALDH1A1TSHR | |
| SCHEMBL11697926 | 0.81 | — | — | |
| SCHEMBL7955782 | 0.79 | — | — | |
| SCHEMBL7955442 | 0.78 | — | — | |
| SCHEMBL6862335 | 0.75 | TSHR (0.38) | ALDH1A1TSHR | |
| SCHEMBL1521232 | 0.75 | TSHR (0.38) | ALDH1A1TSHR | |
| SCHEMBL9232225 | 0.72 | — | — | |
| SCHEMBL29078866 | 0.71 | ALDH1A1 (0.35) | ALDH1A1TSHR | |
| SCHEMBL7186091 | 0.71 | CYP1A2 (0.34) | — | |
| SCHEMBL5319345 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030180665-A1 | Ionization radiation imageable photopolymer compositions | WANG YING (US) | 2003-09-25 | — | — | US | claimed |
| US-6569602-B1 | Radiation curable mixtures comprising monomers, curing agents, sensitizers, binders and/or fillers used for lithography, stereolithography, photoresists and ceramics | E. I. DU PONT DE NEMOURS AND COMPANY | 2003-05-27 | — | — | US | claimed |
| EP-1121623-A1 | IONIZATION RADIATION IMAGEABLE PHOTOPOLYMER COMPOSITIONS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2001-08-08 | — | — | EP | claimed |
| WO-2000020926-A9 | IONIZATION RADIATION IMAGEABLE PHOTOPOLYMER COMPOSITIONS | DU PONT (US) | 2000-09-14 | — | — | WO | claimed |
| WO-2000020926-A1 | IONIZATION RADIATION IMAGEABLE PHOTOPOLYMER COMPOSITIONS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2000-04-13 | — | — | WO | claimed |
| US-8158675-B2 | Compounds and methods for the treatment or prevention of Flavivirus infections | VERTEX PHARMACEUTICALS (CANADA) INCORPORATED (CA) | 2012-04-17 | — | — | US | disclosed |
| US-20100093775-A1 | COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS | VIROCHEM PHARMA INC. (CA) | 2010-04-15 | — | — | US | disclosed |
| EP-1212295-B1 | SUBSTITUTED ALPHA-HYDROXY ACID CASPASE INHIBITORS AND THE USE THEREOF | CYTOVIA INC (US) | 2008-10-01 | — | — | EP | disclosed |
| US-6916598-B2 | Ionization radiation imageable photopolymer compositions | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2005-07-12 | — | — | US | disclosed |
| US-20030180665-A1 | Ionization radiation imageable photopolymer compositions | WANG YING (US) | 2003-09-25 | — | — | US | disclosed |
| US-6569602-B1 | Radiation curable mixtures comprising monomers, curing agents, sensitizers, binders and/or fillers used for lithography, stereolithography, photoresists and ceramics | E. I. DU PONT DE NEMOURS AND COMPANY | 2003-05-27 | — | — | US | disclosed |
| US-6495522-B1 | PREVENTING APOPTOTIC CELL DEATH IN WHICH THE LOSS OF CELLS, TISSUES OR ENTIRE ORGANS OCCURS | CYTOVIA, INC. | 2002-12-17 | — | — | US | disclosed |
| EP-1121623-A1 | IONIZATION RADIATION IMAGEABLE PHOTOPOLYMER COMPOSITIONS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2001-08-08 | — | — | EP | disclosed |
| WO-2000020926-A9 | IONIZATION RADIATION IMAGEABLE PHOTOPOLYMER COMPOSITIONS | DU PONT (US) | 2000-09-14 | — | — | WO | disclosed |
| WO-2000020926-A1 | IONIZATION RADIATION IMAGEABLE PHOTOPOLYMER COMPOSITIONS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2000-04-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100093775-A1 | COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS | ZC3HAV1, YBX1, HAX1 | ALDH1A1 693/4885TSHR 3328/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.